EUVIMEDEUVIMED entdecken
Delphi-StudieOpen Access · CC BY 4.0

Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults: A Delphi Expert Consensus

Rima Obeid iD, Emmanuel Andrès iD, Richard Češka, Babak Hooshmand, Rosa-Maria Guéant-Rodriguez, Gabriel Ioan Prada iD, Jarosław Sławek iD, Latchezar Traykov, Binh Ta Van, Tamás Várkonyi iD, Karlheinz Reiners iD, The Vitamin B Consensus Panelists Group

Journal of Clinical Medicine · 10.04.2024 · 13 (8) · 2176

DOI: 10.3390/jcm13082176 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.04.2024. Verfasst von Rima Obeid und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Laboratory Medicine, Saarland University Hospital, 66421 Homburg, Germany. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wörwag Pharma (Germany), Wörwag Pharma, Germany.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Vitamin B12 deficiency can cause variable symptoms, which may be irreversible if not diagnosed and treated in a timely manner. We aimed to develop a widely accepted expert consensus to guide the practice of diagnosing and treating B12 deficiency.

Methods

We conducted a scoping review of the literature published in PubMed since January 2003. Data were used to design a two-round Delphi survey to study the level of consensus among 42 experts.

Results

The panelists agreed on the need for educational and organizational changes in the current medical practices for diagnosing and treating B12 deficiency. Recognition of clinical symptoms should receive the highest priority in establishing the diagnosis. There is agreement that the serum B12 concentration is useful as a screening marker and methylmalonic acid or homocysteine can support the diagnosis. Patient lifestyle, disease history, and medications can provide clues to the cause of B12 deficiency. Regardless of the cause of the deficiency, initial treatment with parenteral B12 was regarded as the first choice for patients with acute and severe manifestations of B12 deficiency. The use of high-dose oral B12 at different frequencies may be considered for long-term treatment. Prophylactic B12 supplementation should be considered for specific high-risk groups.

Conclusions

There is a consensus that clinical symptoms need to receive more attention in establishing the diagnosis of B12 deficiency. B12 laboratory markers can support the diagnosis. The severity of clinical symptoms, the causes of B12 deficiency, and the treatment goals govern decisions regarding the route and dose of B12 therapy.

Schlagwörter

Stichwörter der Autor:innen

anemiacognitive declinediagnosisneuropathytreatmentvitamin B12 deficiency

Autor:innen und Institutionen

  • Department of Clinical Chemistry and Laboratory Medicine, Saarland University Hospital, 66421 Homburg, Germany.
  • Department of Internal Medicine, Diabetes and Metabolic Diseases, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France.
  • IIIrd Department of Internal Medicine, Center of Preventive Cardiology, University General Hospital, Charles University in Prague, 110 00 Prague, Czech Republic.
  • Aging Research Center, Karolinska Institute, 171 65 Stockholm, Sweden.
  • Department of Neurology, Benedictus Klinikum Tutzing, 82327 Tutzing, Germany.
  • Department of Psychiatry and Psychotherapy, Ludwig Maximillian University Hospital, 80539 Munich, Germany.

ORCID-Profile: Rima Obeid, Emmanuel Andrès, Gabriel Ioan Prada, Jarosław Sławek, Tamás Várkonyi, Karlheinz Reiners

Förderung

  • Wörwag Pharma (Germany)
  • Wörwag Pharma, Germany

Zitieren

APA

Obeid, R., Andrès, E., Češka, R., Hooshmand, B., Guéant-Rodriguez, R. M., Prada, G. I., Sławek, J., Traykov, L., Ta Van, B., Várkonyi, T., Reiners, K., & The Vitamin B Consensus Panelists Group (2024). Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults: A Delphi Expert Consensus. Journal of Clinical Medicine, 13(8), 2176. https://doi.org/10.3390/jcm13082176

Vancouver

Obeid R, Andrès E, Češka R, Hooshmand B, Guéant-Rodriguez RM, Prada GI, et al. Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults: A Delphi Expert Consensus. Journal of Clinical Medicine. 2024;13(8):2176. doi:10.3390/jcm13082176

BibTeX
@article{Obeid2024,
  author = {Obeid, Rima and Andrès, Emmanuel and Češka, Richard and Hooshmand, Babak and Guéant-Rodriguez, Rosa-Maria and Prada, Gabriel Ioan and Sławek, Jarosław and Traykov, Latchezar and Ta Van, Binh and Várkonyi, Tamás and Reiners, Karlheinz and The Vitamin B Consensus Panelists Group},
  title = {Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults: A Delphi Expert Consensus},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {8},
  pages = {2176},
  doi = {10.3390/jcm13082176}
}
Kostenlos starten →